These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 29699580)

  • 1. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
    Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
    Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anti-RANKL treatment reduces muscle inflammation and dysfunction and strengthens bone in dystrophic mice.
    Hamoudi D; Marcadet L; Piette Boulanger A; Yagita H; Bouredji Z; Argaw A; Frenette J
    Hum Mol Genet; 2019 Sep; 28(18):3101-3112. PubMed ID: 31179501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin protects against muscular dystrophy.
    Dufresne SS; Dumont NA; Bouchard P; Lavergne É; Penninger JM; Frenette J
    Am J Pathol; 2015 Apr; 185(4):920-6. PubMed ID: 25708645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice.
    Hamoudi D; Bouredji Z; Marcadet L; Yagita H; Landry LB; Argaw A; Frenette J
    Hum Mol Genet; 2020 Feb; 29(3):483-494. PubMed ID: 31943048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction.
    Dufresne SS; Boulanger-Piette A; Bossé S; Frenette J
    Receptors Clin Investig; 2016 May; 3(2):e13231-e13236. PubMed ID: 27547781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the efficacy of a human full-length OPG-Fc analog in a severe model of cardiotoxin-induced skeletal muscle injury and repair.
    Bouredji Z; Hamoudi D; Marcadet L; Argaw A; Frenette J
    Mol Ther Methods Clin Dev; 2021 Jun; 21():559-573. PubMed ID: 33997104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
    Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
    J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids.
    Atilano-Miguel S; Barbosa-Cortés L; Ortiz-Muñiz R
    Bol Med Hosp Infant Mex; 2022; 79(5):275-283. PubMed ID: 36264895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL Inhibition Reduces Cardiac Hypertrophy in
    Marcadet L; Juracic ES; Khan N; Bouredji Z; Yagita H; Ward LM; Tupling AR; Argaw A; Frenette J
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-RANKL Therapy Prevents Glucocorticoid-Induced Bone Loss and Promotes Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy.
    Jayash SN; Hamoudi D; Stephen LA; Argaw A; Huesa C; Joseph S; Wong SC; Frenette J; Farquharson C
    Calcif Tissue Int; 2023 Oct; 113(4):449-468. PubMed ID: 37470794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANKL signaling drives skeletal muscle into the oxidative profile.
    Cavalcanti de Araújo PH; Cezine MER; Vulczak A; Vieira LC; Matsuo FS; Remoto JM; Santos ADR; Miyabara EH; Alberici LC; Osako MK
    J Bone Miner Res; 2024 Jul; 39(6):753-764. PubMed ID: 38619281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin and β
    Dufresne SS; Boulanger-Piette A; Frenette J
    Am J Pathol; 2017 Mar; 187(3):498-504. PubMed ID: 28041995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors.
    Chen T; Feng X
    Assay Drug Dev Technol; 2006 Aug; 4(4):473-82. PubMed ID: 16945019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy.
    Boulanger Piette A; Hamoudi D; Marcadet L; Morin F; Argaw A; Ward L; Frenette J
    Curr Osteoporos Rep; 2018 Oct; 16(5):541-553. PubMed ID: 30225627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice.
    Widrick JJ; Jiang S; Choi SJ; Knuth ST; Morcos PA
    Muscle Nerve; 2011 Oct; 44(4):563-70. PubMed ID: 21922468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypochlorous acid exposure impairs skeletal muscle function and Ca
    Lea TA; Panizza PM; Arthur PG; Bakker AJ; Pinniger GJ
    J Physiol; 2023 Dec; 601(23):5257-5275. PubMed ID: 37864413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.